Cargando…
Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome
BACKGROUND: The inappropriate secretion of adipocytokines plays a critical role in chronic inflammatory states associated with obesity-linked type 2 diabetes and atherosclerosis. The pleiotropic actions of simvastatin and pioglitazone on epicardial adipose tissue (EAT) are unknown. This study assess...
Autores principales: | Grosso, Adriana Ferreira, de Oliveira, Sérgio Ferreira, Higuchi, Maria de Lourdes, Favarato, Desidério, Dallan, Luís Alberto de Oliveira, da Luz, Protásio Lemos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974153/ https://www.ncbi.nlm.nih.gov/pubmed/24684779 http://dx.doi.org/10.1186/1758-5996-6-47 |
Ejemplares similares
-
Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects
por: Kater, Ana-Lucia A, et al.
Publicado: (2010) -
Comparison of Non-Invasive Methods for the Detection of Coronary Atherosclerosis
por: Bampi, Angela Bacelar Albuquerque, et al.
Publicado: (2009) -
High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
por: da Luz, Protasio Lemos, et al.
Publicado: (2008) -
Inflammatory Genes in Epicardial Fat Contiguous With Coronary Atherosclerosis in the Metabolic Syndrome and Type 2 Diabetes: Changes associated with pioglitazone
por: Sacks, Harold S., et al.
Publicado: (2011) -
Pioglitazone/simvastatin: Acute kidney injury secondary to rhabdomyolysis: case report
Publicado: (2021)